Intuitive Surgical (NASDAQ:ISRG) is scheduled to announce its earnings results after the market closes on Thursday, April 18th. Analysts expect the company to announce earnings of $2.26 per share for the quarter.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 24th. The medical equipment provider reported $2.96 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $3.07 by ($0.11). The company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.05 billion. Intuitive Surgical had a net margin of 30.29% and a return on equity of 18.11%. Intuitive Surgical’s revenue was up 17.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.54 EPS. On average, analysts expect Intuitive Surgical to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

ISRG opened at $576.81 on Tuesday. The stock has a market cap of $67.44 billion, a price-to-earnings ratio of 60.78, a P/E/G ratio of 4.59 and a beta of 1.10. Intuitive Surgical has a 52-week low of $417.68 and a 52-week high of $589.32.

Several equities analysts have issued reports on ISRG shares. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, January 30th. Cantor Fitzgerald restated a “buy” rating and set a $620.00 target price on shares of Intuitive Surgical in a research note on Friday, January 25th. Stifel Nicolaus reduced their price target on shares of Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating for the company in a research report on Friday, January 25th. Citigroup reduced their price target on shares of Intuitive Surgical from $601.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, January 2nd. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $540.00 price target for the company in a research report on Wednesday, December 19th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $576.17.

In related news, COO Salvatore Brogna sold 2,090 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $551.79, for a total value of $1,153,241.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Jamie Samath sold 458 shares of the stock in a transaction that occurred on Tuesday, January 29th. The stock was sold at an average price of $500.03, for a total transaction of $229,013.74. Following the completion of the sale, the vice president now directly owns 198 shares of the company’s stock, valued at $99,005.94. The disclosure for this sale can be found here. Insiders have sold a total of 42,284 shares of company stock valued at $22,205,382 in the last ninety days. Insiders own 1.70% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.thecerbatgem.com/2019/04/16/intuitive-surgical-isrg-scheduled-to-post-quarterly-earnings-on-thursday.html.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Read More: What is a good rate of return for a mutual fund?

Earnings History for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.